These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Homocysteine metabolism and its role in pathology]. Pentiuk OO; Lutsiuk MB; Andrushko II; Postovitenko KP Ukr Biokhim Zh (1999); 2003; 75(1):5-17. PubMed ID: 14574730 [TBL] [Abstract][Full Text] [Related]
47. Low diagnostic value of fasting and post-methionine load homocysteine tests. A study in Dutch subjects with homocysteine test indications. Fokkema MR; Dijck-Brouwer DA; van Doormaal JJ; Reijngoud DJ; Muskiet FA Clin Chim Acta; 2003 May; 331(1-2):153-7. PubMed ID: 12691876 [TBL] [Abstract][Full Text] [Related]
48. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Škovierová H; Vidomanová E; Mahmood S; Sopková J; Drgová A; Červeňová T; Halašová E; Lehotský J Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775595 [TBL] [Abstract][Full Text] [Related]
50. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs]. Shakhmatova OO; Komarov AL; Panchenko EP Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157 [TBL] [Abstract][Full Text] [Related]
51. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models. Wilson KM; Lentz SR Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268 [TBL] [Abstract][Full Text] [Related]
52. Protective role of mast cells in homocysteine-induced cardiac remodeling. Joseph J; Kennedy RH; Devi S; Wang J; Joseph L; Hauer-Jensen M Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2541-5. PubMed ID: 15591099 [TBL] [Abstract][Full Text] [Related]
54. [Hyperhomocysteinemia and cardiometabolic risk]. Vannucchi H; Melo SS Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):540-9. PubMed ID: 19768245 [TBL] [Abstract][Full Text] [Related]
55. Hyperhomocysteinemia and lower extremity wounds. Schwartzfarb EM; Romanelli P Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388 [TBL] [Abstract][Full Text] [Related]
56. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients. Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266 [TBL] [Abstract][Full Text] [Related]
57. Homocysteine: is it a clinically important cardiovascular risk factor? Lentz SR; Haynes WG Cleve Clin J Med; 2004 Sep; 71(9):729-34. PubMed ID: 15478704 [TBL] [Abstract][Full Text] [Related]
58. Study of the Inflammatory Mechanisms in Hyperhomocysteinemia on Large-Artery Atherosclerosis Based on Hypersensitive C-Reactive Protein-A Study from Southern China. Cao L; Guo Y; Zhu Z J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1816-1823. PubMed ID: 31080137 [TBL] [Abstract][Full Text] [Related]
59. Homocysteine in uremia. Perna AF; Ingrosso D; Lombardi C; Cesare CM; Acantora F; Satta E; De Santo NG Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S123-6. PubMed ID: 12612968 [TBL] [Abstract][Full Text] [Related]
60. Homocysteine as a risk factor for atherosclerosis. Temple ME; Luzier AB; Kazierad DJ Ann Pharmacother; 2000 Jan; 34(1):57-65. PubMed ID: 10669187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]